Jeliazko I. Arabadjiev

BG 
BG 

Overview

Jeliazko Arabadjiev practices practicing medicine in Bulgaria.

Their clinical expertise encompasses Fetal Parvovirus Syndrome, Teratoma of the Mediastinum, Lung Cancer, and Parvovirus Antenatal Infection.

They are actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 1 clinical trial.

Locations

1407, Bulgaria
Other Locations
Sofia, 1431, Bulgaria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Enrollment Status: Completed
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drugs: Mirvetuximab Soravtansine, Paclitaxel, Topotecan, Pegylated liposomal doxorubicin
Study Phase: Phase 3

10 Total Publications

Prevalence of Homologous Recombination Deficiency and Treatment Patterns in Patients with Newly Diagnosed Advanced Ovarian Cancer in Bulgaria: A Real-World Cohort Study (VALIDATE).
Prevalence of Homologous Recombination Deficiency and Treatment Patterns in Patients with Newly Diagnosed Advanced Ovarian Cancer in Bulgaria: A Real-World Cohort Study (VALIDATE).
Journal: Medicina (Kaunas, Lithuania)
Published: March 05, 2026

Frequently Asked Questions about Jeliazko I. Arabadjiev

Is Jeliazko I. Arabadjiev a top-rated expert for Fetal Parvovirus Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Jeliazko I. Arabadjiev is classified as an Experienced expert for Fetal Parvovirus Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jeliazko I. Arabadjiev participate in research or clinical trials?

Yes. Jeliazko I. Arabadjiev has published 10 articles and abstracts on conditions like Fetal Parvovirus Syndrome. You can view a list of Jeliazko I. Arabadjiev's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Arabadjiev's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile